myoglobin (
M0630, Sigma Aldrich Corporation, St. Louis, MO, USA) and
ascorbic acid (Sigma) were dissolved in Dulbecco’s Modified Eagle Medium(DMEM):Nutrient Mixture F-12 media(DMEM/F12, Gibco, Life Technologies Corporation, Carlsbad, CA, USA) to make the storage solution. The storage solution was diluted to a proper concentration just before each experiment. A concentration of 200 mM (i.e., 3.6 g/L) ferrous
myoglobin was used in this study. Only reduced
myoglobin is cytotoxic, but only met
myoglobin was commercially available, so the
myoglobin and
ascorbic acid solutions were mixed to make the ferrous
myoglobin mediumas described in the literature32 (
link). The final concentration of
myoglobin was 200 mM, while
ascorbic acid was 2 mM. The
ascorbic acid had reduced
myoglobin to ferrous status when the color changed from brown to reddish.
The following groups were evaluated: Con, HK-2 cells in normal media; Mb, HK-2 cells in ferrous
myoglobin medium; Mb + MSCs, HK-2 cells in ferrous
myoglobin medium co-culture with MSCs in 6- or 96-well transwell plates. Mb + MSCs +
LY294002, HK-2 cells in ferrous
myoglobin medium were co-culture with MSCs in 6- or 96-well transwell plates with the PI3K inhibitor,
LY294002 (25 μmol/L) (Sigma).
Geng X., Hong Q., Wang W., Zheng W., Li O., Cai G., Chen X, & Wu D. (2017). Biological Membrane-Packed Mesenchymal Stem Cells Treat Acute Kidney Disease by Ameliorating Mitochondrial-Related Apoptosis. Scientific Reports, 7, 41136.